Business

American Renal Associates Holdings, Inc. (NYSE: ARA) Investor Investigation over potential Wrongdoing

An investigation on behalf of current long-term investors in shares of American Renal Associates Holdings, Inc. (NYSE: ARA) was announced over potential breaches of fiduciary duties by certain officers and directors at American Renal Associates Holdings, Inc.

Investors who purchased shares of American Renal Associates Holdings, Inc. (NYSE: ARA) and currently hold any of those NYSE: ARA shares have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554.

The investigation by a law firm concerns whether certain American Renal Associates Holdings, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

On March 28, 2019, a lawsuit was filed against American Renal Associates Holdings, Inc. (NYSE: ARA) over alleged violations of Federal Securities Laws. The plaintiff alleged that the defendants violated Federal Securities Laws.

Those who purchased shares of American Renal Associates Holdings, Inc. (NYSE: ARA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
[email protected]

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.